0001493152-22-033241.txt : 20221122
0001493152-22-033241.hdr.sgml : 20221122
20221122080013
ACCESSION NUMBER: 0001493152-22-033241
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221118
FILED AS OF DATE: 20221122
DATE AS OF CHANGE: 20221122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Meckler Jeffrey A
CENTRAL INDEX KEY: 0001506916
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40652
FILM NUMBER: 221407519
MAIL ADDRESS:
STREET 1: 740 BROADWAY
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001857044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863158720
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (646) 427-2727
MAIL ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: Intec Parent Inc.
DATE OF NAME CHANGE: 20210414
4
1
ownership.xml
X0306
4
2022-11-18
0
0001857044
Indaptus Therapeutics, Inc.
INDP
0001506916
Meckler Jeffrey A
C/O INDAPTUS THERAPEUTICS, INC
3 COLUMBUS CIRCLE, 15TH FLOOR
NEW YORK
NY
10019
1
1
0
0
CEO and Director
Common stock
2022-11-18
2022-11-18
4
P
0
400
1.7637
A
65774
D
Common stock
2022-11-21
2022-11-21
4
P
0
9600
1.90
A
75374
D
/s/ Jeffrey Meckler
2022-11-22